148 related articles for article (PubMed ID: 11404034)
1. Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2.
Krishna G; Chen K; Lin C; Nomeir AA
Int J Pharm; 2001 Jul; 222(1):77-89. PubMed ID: 11404034
[TBL] [Abstract][Full Text] [Related]
2. [Absorption and transport of isoflavonoid compounds from Tongmai formula across human intestinal epithelial (Caco-2) cells in vitro].
Wang FR; Yang XW
Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(16):3206-3212. PubMed ID: 29171242
[TBL] [Abstract][Full Text] [Related]
3. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices.
Westerhout J; van de Steeg E; Grossouw D; Zeijdner EE; Krul CA; Verwei M; Wortelboer HM
Eur J Pharm Sci; 2014 Oct; 63():167-77. PubMed ID: 25046168
[TBL] [Abstract][Full Text] [Related]
4. The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compounds.
Aungst BJ; Nguyen NH; Bulgarelli JP; Oates-Lenz K
Pharm Res; 2000 Oct; 17(10):1175-80. PubMed ID: 11145221
[TBL] [Abstract][Full Text] [Related]
5. Effect of bovine serum albumin on drug permeability estimation across Caco-2 monolayers.
Saha P; Kou JH
Eur J Pharm Biopharm; 2002 Nov; 54(3):319-24. PubMed ID: 12445562
[TBL] [Abstract][Full Text] [Related]
6. Using Human Plasma as an Assay Medium in Caco-2 Studies Improves Mass Balance for Lipophilic Compounds.
Katneni K; Pham T; Saunders J; Chen G; Patil R; White KL; Abla N; Chiu FCK; Shackleford DM; Charman SA
Pharm Res; 2018 Sep; 35(11):210. PubMed ID: 30225649
[TBL] [Abstract][Full Text] [Related]
7. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
8. The impact of protein on Caco-2 permeability of low mass balance compounds for absorption projection and efflux substrate identification.
Liu T; Chang LJ; Uss A; Chu I; Morrison RA; Wang L; Prelusky D; Cheng KC; Li C
J Pharm Biomed Anal; 2010 Apr; 51(5):1069-77. PubMed ID: 20036089
[TBL] [Abstract][Full Text] [Related]
9. Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs.
Fossati L; Dechaume R; Hardillier E; Chevillon D; Prevost C; Bolze S; Maubon N
Int J Pharm; 2008 Aug; 360(1-2):148-55. PubMed ID: 18539418
[TBL] [Abstract][Full Text] [Related]
10. Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line.
Grès MC; Julian B; Bourrié M; Meunier V; Roques C; Berger M; Boulenc X; Berger Y; Fabre G
Pharm Res; 1998 May; 15(5):726-33. PubMed ID: 9619781
[TBL] [Abstract][Full Text] [Related]
11. [Absorption of papaverine, laudanosine and cepharanthine across human intestine by using human Caco-2 cells monolayers model].
Ma L; Yang XW
Yao Xue Xue Bao; 2008 Feb; 43(2):202-7. PubMed ID: 18507350
[TBL] [Abstract][Full Text] [Related]
12. Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway.
Schumacher-Klinger A; Fanous J; Merzbach S; Weinmüller M; Reichart F; Räder AFB; Gitlin-Domagalska A; Gilon C; Kessler H; Hoffman A
Mol Pharm; 2018 Aug; 15(8):3468-3477. PubMed ID: 29976060
[TBL] [Abstract][Full Text] [Related]
13. [Absorption and transport of 6 coumarins isolated from the roots of Angelica pubescens f. biserrata in human Caco-2 cell monolayer model].
Yang XW; Guo QM; Wang Y
Zhong Xi Yi Jie He Xue Bao; 2008 Apr; 6(4):392-8. PubMed ID: 18405608
[TBL] [Abstract][Full Text] [Related]
14. Addition of Optimized Bovine Serum Albumin Level in a High-Throughput Caco-2 Assay Enabled Accurate Permeability Assessment for Lipophilic Compounds.
Cai X; Madari S; Walker A; Paiva A; Li Y; Herbst J; Shou W; Weller H
SLAS Discov; 2019 Aug; 24(7):738-744. PubMed ID: 31076010
[TBL] [Abstract][Full Text] [Related]
15. The influence of plasma binding on absorption/exsorption in the Caco-2 model of human intestinal absorption.
Walgren RA; Walle T
J Pharm Pharmacol; 1999 Sep; 51(9):1037-40. PubMed ID: 10528987
[TBL] [Abstract][Full Text] [Related]
16. Optimisation of the caco-2 permeability assay using experimental design methodology.
Lakeram M; Lockley DJ; Pendlington R; Forbes B
Pharm Res; 2008 Jul; 25(7):1544-51. PubMed ID: 18293061
[TBL] [Abstract][Full Text] [Related]
17. Absorption and transport of pachymic acid in the human intestinal cell line Caco-2 monolayers.
Zheng Y; Yang XW
Zhong Xi Yi Jie He Xue Bao; 2008 Jul; 6(7):704-10. PubMed ID: 18601852
[TBL] [Abstract][Full Text] [Related]
18. Accelerated Caco-2 cell permeability model for drug discovery.
Sevin E; Dehouck L; Fabulas-da Costa A; Cecchelli R; Dehouck MP; Lundquist S; Culot M
J Pharmacol Toxicol Methods; 2013; 68(3):334-9. PubMed ID: 23916595
[TBL] [Abstract][Full Text] [Related]
19. Sodium glycocholate transport across Caco-2 cell monolayers, and the enhancement of mannitol transport relative to transepithelial electrical resistance.
Lindhardt K; Bechgaard E
Int J Pharm; 2003 Feb; 252(1-2):181-6. PubMed ID: 12550793
[TBL] [Abstract][Full Text] [Related]
20. Effect of solubilizing excipients on permeation of poorly water-soluble compounds across Caco-2 cell monolayers.
Saha P; Kou JH
Eur J Pharm Biopharm; 2000 Nov; 50(3):403-11. PubMed ID: 11072198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
